AzTrials
AzTrials

Healthy VolunteersEarly Phase 1METABORANGENCT02685124

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

A Early Phase 1 study testing Orange juice in people with Healthy Volunteers, run by University of Sao Paulo.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric control drink in a cross-over study. Read more about this study

Who is it for?
Ages 20 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
Orange juice
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
21 participants
Where
No sites listed yet
Study dates
Sep 2015to Feb 2016
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Subjects like to drink orange juice

Who cannot join

  • History of cardiovascular disease
  • History of gastrointestinal, liver or kidney disease
  • History of alcoholism
  • Diabetes and metabolic diseases
  • Pregnant, trying to became pregnant or breast feeding
  • Smokers
  • To make use of vitamin and mineral supplements, antibiotics, antiacids, any drugs

About this study

Official title: Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans: a Comparative Study Between "Bahia" and "Cara Cara" Orange Varieties.

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric control drink in a cross-over study.

Read the detailed description

The consumption of fruits and vegetables is linked to a decrease in the incidence of chronic diseases. Citrus fruits represent the main source of bioactive compounds such as flavonoids, vitamin C and carotenoids in the brazilian diet.

Unlike the "Bahia", the "Cara Cara" variety which is a spontaneous mutation of "Washington navel" orange is characterized by a bright red pulp due to high levels of lycopene. This difference in the chemical composition may lead to a different biological activity and then a greater protective effect on health.

Since the biological effects generated from a food intake are the result of the interaction of various nutrients with different metabolic pathways, the investigators will apply the metabolomic approach to investigate the complex relationships between fruit intake, bioactive compounds and human metabolism. The investigators will propose to describe the metabolic pathways affected by orange juice intake and to identify biomarkers that can be used in nutritional interventions.

Being tested
Orange juice

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orange juiceDietary supplement

    Three days before the start of the study, all participants will restrict their diet avoiding citrus fruits (orange, tangerine, lemon) and its derivatives (washout period), red fruits and vegetables (strawberry, red lettuce, red grape, tomate). The day before the sample collection will be provided a controlled dinner. A fasting for 8 hours will be required before blood and urine collection. All participants will divided into three groups: I (Cara Cara), II (Bahia), III (Isocaloric control drink). They will consume 250 ml of each drink twice daily for 7 consecutive days, with a washout period of 7 days among each intervention.

Study groups in NCT02685124
Study groupRoleWhat they receive
Bahia orange juiceExperimental250 ml twice daily for 7 days
Receives: Dietary Supplement: Orange juice
Cara Cara orange juiceExperimental250 ml twice daily for 7 days
Receives: Dietary Supplement: Orange juice
Isocaloric control drinkPlacebo comparator250 ml twice daily for 7 days
Receives: Dietary Supplement: Orange juice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative changes in urinary metabolome will be evaluated by Gas Chromatography coupled to Mass Spectrometry (GC-MS) and Liquid Chromatography coupled to Mass Spectrometry (LC-MS).

    Measured: Urine collection will be performed at time 0, after 3, 6 hours and 7 days of treatment.

Secondary outcomes (3)
  1. Changes in the antioxidant enzymes will be evaluated in serum samples in different time points.

    Measured: Blood collection will be performed at time 0, after 3, 6 hours and 7 days of treatment

  2. Changes in the miRNAs expression will be evaluated in plasma samples in different time points.

    Measured: Blood collection will be performed at time 0, after 3, 6 hours and 7 days of treatment

  3. Qualitative and quantitative changes in fecal metabolome will be evaluated by an untargeted metabolomic approach based on Nuclear Magnetic Resonance spectroscopy (NMR).

    Measured: Feces collection will be performed at time 0 and after 7 days of treatment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2016 (estimated)
  2. Study startSep 2015
  3. Primary completionOct 2015
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02685124
Sponsor's protocol ID
CEP FCF 1097907
Acronym
METABORANGE
Status last verified
Feb 2016
First submitted
4 Feb 2016
Last updated
18 Feb 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: February 2017

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Orange juice in people with Healthy Volunteers, run by University of Sao Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative changes in urinary metabolome will be evaluated by Gas Chromatography coupled to Mass Spectrometry (GC-MS) and Liquid Chromatography coupled to Mass Spectrometry (LC-MS). (time frame: Urine collection will be performed at time 0, after 3, 6 hours and 7 days of treatment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in